SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
-----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
October 24, 2001
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware 1-4389 06-1534213
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File No.) Identification No.)
301 Merritt 7
Norwalk, Connecticut 06851
(Address of Principal Executive Offices, Including Zip Code)
(203) 840-2000
(Registrant's telephone number, including area code)
Item 5. Other Events and Regulation FD Disclosure.
Attached hereto as Exhibit 99.1 and 99.2 and incorporated by reference
herein are the texts of press releases (the "Press Releases") issued October 24,
2001 by Applera Corporation ("Applera") regarding fiscal year 2002 first quarter
results for Applera's Applied Biosystems and Celera Genomics groups.
Beginning in the fourth quarter of fiscal year 2001, Applera's Applied
Biosystems group commenced the reporting of net revenues by product category.
For reference purposes, the comparable classification of quarterly net revenues
for fiscal year 2001 is as follows:
Revenues (Dollar amounts in millions) Q1 Q2 Q3 Q4 FY01
------------------------------------- -- -- -- -- ----
Instruments, including software $185.0 $207.7 $229.2 $191.4 $ 813.3
Percent of Net Revenues 50.9% 50.5% 52.1% 47.2% 50.2%
Consumables $124.5 $150.3 $159.0 $158.3 $ 592.1
Percent of Net Revenues 34.2% 36.6% 36.2% 39.1% 36.6%
Other Sources $ 54.1 $ 53.0 $ 51.6 $ 55.4 $ 214.1
Percent of Net Revenues 14.9% 12.9% 11.7% 13.7% 13.2%
Net Revenues $363.6 $411.0 $439.8 $405.1 $1,619.5
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibits are filed with this Report:
Exhibit No. Description
99.1 Press Release issued October 24, 2001 with respect
to the Applied Biosystems group.
99.2 Press Release issued October 24, 2001 with respect
to the Celera Genomics group.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLERA CORPORATION
By: /s/ Dennis L. Winger
--------------------------------------
Dennis L. Winger
Senior Vice President and
Chief Financial Officer
Dated: October 24, 2001
EXHIBIT INDEX
Exhibit No. Description
99.1 Press Release issued October 24, 2001 with respect
to the Applied Biosystems group.
99.2 Press Release issued October 24, 2001 with respect
to the Celera Genomics group.